Myseum Inc - Warrants - Series A (MYSEW) Financials

$0.04 -0.01 (-22.41%)

As of 01:10 PM Eastern

Annual Income Statements for Myseum Inc - Warrants - Series A

This table shows Myseum Inc - Warrants - Series A's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-0.98	-11	-12	-8.40	-4.24	-4.82
Consolidated Net Income / (Loss)	-0.98	-11	-12	-8.40	-5.03	-5.65
Net Income / (Loss) Continuing Operations	-0.98	-11	-12	-8.40	-2.95	-5.25
Total Pre-Tax Income	-0.98	-11	-12	-8.40	-2.95	-5.25
Total Operating Income	-1.08	-11	-12	-8.78	-3.22	-5.49
Total Gross Profit	0.00	0.00	0.05	0.00	0.00	0.00
Total Revenue	0.00	0.00	0.05	0.00	0.00	0.00
Operating Revenue	0.00	0.00	0.05	0.00	0.00	0.00
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	1.08	11	12	8.78	3.22	5.49
Selling, General & Admin Expense	0.11	0.61	0.99	2.22	1.17	2.14
Marketing Expense	0.22	5.09	0.83	0.39	0.08	0.24
Research & Development Expense	-	0.00	0.51	1.35	0.17	0.00
Other Operating Expenses / (Income)	0.76	5.14	8.84	4.76	1.79	3.11
Total Other Income / (Expense), net	0.10	0.00	0.04	0.38	0.27	0.24
Interest Expense	-0.10	0.00	0.00	-0.04	0.00	-0.06
Interest & Investment Income	0.00	0.00	0.01	0.38	0.27	0.17
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	0.00	-0.79	-0.43
Basic Earnings per Share	($0.07)	($0.71)	($6.04)	($4.14)	($1.43)	($0.62)
Weighted Average Basic Shares Outstanding	13.25M	15.33M	2.01M	2.03M	2.96M	4.20M
Diluted Earnings per Share	($0.07)	-	-	($4.14)	($1.43)	($0.62)
Weighted Average Diluted Shares Outstanding	13.25M	15.33M	20.23M	2.03M	2.96M	4.20M
Weighted Average Basic & Diluted Shares Outstanding	13.25M	15.33M	20.23M	3.01M	4.28M	4.32M

This table shows Myseum Inc - Warrants - Series A's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-2.36	-1.35	-1.14	-0.98	-1.27	-0.85	-1.47	-1.22	-1.20	-0.93	-2.86
Consolidated Net Income / (Loss)	-2.36	-1.35	-1.56	-1.20	-1.18	-1.08	-1.62	-1.36	-1.23	-1.44	-2.86
Net Income / (Loss) Continuing Operations	-2.36	-1.35	-1.56	-1.20	-1.18	1.00	-1.39	-1.36	-1.23	-1.05	-2.86
Total Pre-Tax Income	-2.36	-1.35	-1.56	-1.20	-1.18	1.00	-1.39	-1.36	-1.23	-1.05	-2.86
Total Operating Income	-2.54	-1.49	-1.66	-1.27	-1.24	0.95	-1.43	-1.41	-1.28	-1.14	-1.69
Total Gross Profit	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Operating Expenses	2.54	1.49	1.66	1.27	1.24	-0.95	1.43	1.41	1.28	1.14	1.69
Selling, General & Admin Expense	0.70	0.51	0.50	0.49	0.38	-0.19	0.48	0.65	0.45	0.39	0.66
Marketing Expense	0.22	0.01	0.03	0.03	0.03	-0.02	0.03	0.07	0.05	0.07	0.23
Other Operating Expenses / (Income)	1.25	0.58	0.90	0.52	0.46	-0.09	0.92	0.68	0.78	0.69	0.80
Total Other Income / (Expense), net	0.18	0.14	0.10	0.06	0.05	0.05	0.04	0.05	0.05	0.10	-1.18
Interest & Investment Income	0.18	0.10	0.11	0.06	0.05	0.04	0.04	0.05	0.05	0.03	0.02
Other Income / (Expense), net	-0.00	-	-0.01	0.00	0.00	0.01	0.00	0.00	0.00	-	-1.19
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-0.23	-	-	-	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-	-0.42	-0.22	0.09	-0.23	-0.15	-0.14	-0.03	-0.12	0.00
Basic Earnings per Share	($1.13)	($0.67)	($0.41)	($0.33)	($0.42)	($0.29)	($0.36)	($0.29)	($0.28)	$0.31	($0.67)
Weighted Average Basic Shares Outstanding	2.09M	2.03M	2.81M	3.01M	3.01M	2.96M	4.09M	4.21M	4.22M	4.20M	4.28M
Diluted Earnings per Share	($1.13)	($0.67)	($0.41)	($0.33)	($0.42)	($0.29)	($0.36)	($0.29)	($0.28)	$0.31	($0.67)
Weighted Average Diluted Shares Outstanding	2.09M	2.03M	2.81M	3.01M	3.01M	2.96M	4.09M	4.21M	4.22M	4.20M	4.28M
Weighted Average Basic & Diluted Shares Outstanding	2.10M	3.01M	3.01M	3.01M	3.01M	4.28M	4.21M	4.21M	4.26M	4.32M	5.07M

This table details how cash moves in and out of Myseum Inc - Warrants - Series A's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.62	20	-18	-0.77	-0.18	-0.02
Net Cash From Operating Activities	-1.10	-8.45	-7.26	-6.53	-4.81	-4.27
Net Cash From Continuing Operating Activities	-1.10	-8.45	-7.26	-6.53	-4.81	-4.24
Net Income / (Loss) Continuing Operations	-0.98	-11	-12	-8.40	-5.03	-3.04
Consolidated Net Income / (Loss)	-0.98	-11	-12	-8.40	-5.03	-3.04
Depreciation Expense	0.00	0.00	0.13	0.03	0.02	0.04
Amortization Expense	0.02	0.04	0.05	0.06	0.07	0.03
Non-Cash Adjustments To Reconcile Net Income	-0.12	2.30	4.52	1.95	-0.11	-1.63
Changes in Operating Assets and Liabilities, net	-0.02	0.03	0.18	-0.17	0.23	0.35
Net Cash From Investing Activities	0.00	-0.06	-11	6.16	2.24	-0.24
Net Cash From Continuing Investing Activities	0.00	-0.06	-11	6.16	2.24	-0.24
Purchase of Property, Plant & Equipment	0.00	-0.06	-0.04	-0.05	0.00	-0.00
Acquisitions	-	0.00	-0.23	-	0.00	-0.20
Purchase of Investments	-	0.00	-21	-8.60	-11	-6.42
Sale and/or Maturity of Investments	-	0.00	9.91	15	13	6.39
Other Investing Activities, net	-	-	0.00	0.06	0.00	-0.01
Net Cash From Financing Activities	1.72	28	0.00	-0.40	2.39	4.49
Net Cash From Continuing Financing Activities	1.72	28	0.00	-0.40	2.39	4.49
Issuance of Debt	0.27	0.18	-	-	0.00	0.04
Issuance of Common Equity	1.88	28	-	0.00	2.39	4.53
Other Financing Activities, net	-	-	-	-	0.00	-0.08
Cash Interest Paid	0.00	0.00	0.00	0.00	0.00	0.01
Cash Income Taxes Paid	0.00	0.00	0.00	0.00	0.00	0.00

This table details how cash moves in and out of Myseum Inc - Warrants - Series A's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-0.39	0.29	-0.70	0.34	0.04	0.14	0.28	-0.86	0.05	0.72	0.03
Net Cash From Operating Activities	-1.98	-1.37	-1.48	-1.07	-0.96	-1.30	-1.19	-1.21	-0.90	-0.75	-1.25
Net Cash From Continuing Operating Activities	-1.98	-1.37	-1.48	-1.07	-0.96	-1.30	-1.19	-1.21	-0.90	-0.72	-1.25
Net Income / (Loss) Continuing Operations	-2.36	-1.35	-1.56	-1.20	-1.18	-1.08	-1.62	-1.36	-1.23	1.17	-2.86
Consolidated Net Income / (Loss)	-2.36	-1.35	-1.56	-1.20	-1.18	-1.08	-1.62	-1.36	-1.23	1.17	-2.86
Depreciation Expense	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.00
Amortization Expense	0.02	0.02	0.02	0.02	0.02	0.02	0.00	0.01	0.01	0.01	0.01
Non-Cash Adjustments To Reconcile Net Income	0.60	-0.02	0.07	0.06	0.18	-0.42	0.38	0.16	0.22	-2.16	1.63
Changes in Operating Assets and Liabilities, net	-0.23	-0.02	-0.01	0.05	0.02	0.17	0.05	-0.02	0.08	0.24	-0.03
Net Cash From Investing Activities	1.58	1.66	-0.65	1.18	0.74	0.97	-2.91	0.37	0.94	1.34	1.35
Net Cash From Continuing Investing Activities	1.58	1.66	-0.65	1.18	0.74	0.97	-2.91	0.37	0.94	1.34	1.35
Acquisitions	-	-	0.00	-	-	-	-0.07	-0.10	-0.02	-0.01	0.00
Purchase of Investments	-4.40	-3.24	-3.34	-2.26	-2.89	-2.28	-4.31	-1.00	-0.51	-0.59	-1.09
Sale and/or Maturity of Investments	6.00	4.90	2.69	3.43	3.64	3.25	1.48	1.48	1.47	1.96	2.44
Net Cash From Financing Activities	0.00	-	1.42	0.24	0.26	0.48	4.38	-0.02	0.01	0.13	-0.07
Net Cash From Continuing Financing Activities	0.00	-	1.42	0.24	0.26	0.48	4.38	-0.02	0.01	0.13	-0.07
Issuance of Debt	-	-	-	-	-	-	4.53	-	-	-	0.00
Other Financing Activities, net	-	-	-	-	-	-	-0.15	-	-	-	-0.07
Cash Interest Paid	-	-	0.00	-	-	-	0.00	0.00	0.00	-	0.00
Cash Income Taxes Paid	-	-	0.00	-	-	-	0.00	-	-	-	0.00

This table presents Myseum Inc - Warrants - Series A's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	0.74	21	13	6.51	5.37	7.20
Total Current Assets	0.72	21	13	6.38	4.29	3.97
Cash & Equivalents	0.69	20	1.73	0.95	0.77	0.75
Short-Term Investments	-	0.00	11	5.24	2.95	2.98
Accounts Receivable	-	0.00	0.00	0.00	0.00	0.00
Prepaid Expenses	0.03	0.38	0.13	0.19	0.12	0.24
Plant, Property, & Equipment, net	0.00	0.05	0.08	0.06	0.03	0.02
Total Noncurrent Assets	0.03	0.18	0.13	0.07	1.05	3.21
Long-Term Investments	-	-	-	-	0.00	2.92
Other Noncurrent Operating Assets	0.03	0.18	0.13	0.07	0.00	0.29
Total Liabilities & Shareholders' Equity	0.74	21	13	6.51	5.37	7.20
Total Liabilities	0.16	0.73	0.56	0.41	0.63	1.09
Total Current Liabilities	0.16	0.58	0.47	0.41	0.63	0.92
Accounts Payable	0.12	0.52	0.40	0.32	0.60	0.87
Current Deferred Revenue	-	0.01	0.00	0.00	0.00	0.00
Other Current Liabilities	0.04	0.05	0.07	0.08	0.00	0.05
Total Noncurrent Liabilities	0.00	0.15	0.08	0.00	0.00	0.17
Other Noncurrent Operating Liabilities	-	0.15	0.08	-	0.00	0.17
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	0.58	20	13	6.10	4.74	6.10
Total Preferred & Common Equity	0.58	20	13	6.10	6.88	6.10
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	0.58	20	13	6.10	6.88	6.10
Common Stock	17	48	52	55	60	61
Retained Earnings	-17	-28	-40	-48	-52	-55
Treasury Stock	-	-	0.00	-0.40	-0.40	-0.40
Other Equity Adjustments	0.00	0.00	-	-	0.00	0.00

This table presents Myseum Inc - Warrants - Series A's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	7.98	6.42	5.44	4.82	8.51	7.45	6.76	4.95
Total Current Assets	7.78	6.32	5.35	4.76	7.21	5.79	5.08	2.86
Cash & Equivalents	0.67	0.25	0.59	0.63	1.27	0.41	0.46	0.78
Short-Term Investments	6.83	5.84	4.66	3.92	5.79	5.31	4.35	1.59
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Prepaid Expenses	0.28	0.23	0.11	0.20	0.15	0.07	0.28	0.49
Plant, Property, & Equipment, net	0.11	0.05	0.05	0.04	0.03	0.03	0.02	0.01
Total Noncurrent Assets	0.09	0.06	0.04	0.02	1.28	1.64	1.66	2.07
Long-Term Investments	-	-	-	-	-	-	-	1.73
Other Noncurrent Operating Assets	0.09	0.06	0.04	0.02	0.15	0.41	0.43	0.35
Total Liabilities & Shareholders' Equity	7.98	6.42	5.44	4.82	8.51	7.45	6.76	4.95
Total Liabilities	0.49	0.45	0.41	0.53	0.70	0.84	1.07	1.08
Total Current Liabilities	0.47	0.45	0.41	0.53	0.70	0.64	0.89	0.93
Accounts Payable	0.39	0.38	0.36	0.51	0.70	0.60	0.80	0.87
Current Deferred Revenue	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Other Current Liabilities	0.08	0.06	0.04	0.02	0.00	0.05	0.05	0.05
Total Noncurrent Liabilities	0.02	0.00	0.00	0.00	0.00	0.19	0.18	0.15
Other Noncurrent Operating Liabilities	0.02	-	-	-	-	0.19	0.18	0.15
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	7.48	5.98	5.03	4.29	7.81	6.61	5.69	3.87
Total Preferred & Common Equity	7.48	6.84	6.12	7.08	10	9.22	8.34	3.87
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	7.48	6.84	6.12	7.08	10	9.22	8.34	3.87
Common Stock	55	57	57	59	65	65	65	62
Retained Earnings	-47	-49	-50	-52	-54	-55	-56	-58
Treasury Stock	-0.40	-0.40	-0.40	-0.40	-0.40	-0.40	-0.40	-0.40
Other Equity Adjustments	-	-	-	-	0.00	-	0.00	0.00

This table displays calculated financial ratios and metrics derived from Myseum Inc - Warrants - Series A's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	19,597,419.00	20,597,419.00	2,103,321.00	2,103,321.00	2,103,321.00
DEI Adjusted Shares Outstanding	0.00	1,959,742.00	2,059,742.00	2,103,321.00	2,103,321.00	2,103,321.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-5.53	-5.89	-4.00	-2.02	-2.29
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	939.69%	-98.55%	-35.12%	26.15%
EBITDA Growth	0.00%	-924.51%	-11.38%	27.28%	64.31%	-73.56%
EBIT Growth	0.00%	-905.96%	-12.55%	27.60%	63.57%	-70.65%
NOPAT Growth	0.00%	-899.47%	-12.81%	28.16%	63.37%	-70.65%
Net Income Growth	0.00%	-1,005.60%	-12.09%	30.76%	40.21%	-12.39%
EPS Growth	0.00%	0.00%	0.00%	0.00%	65.46%	56.64%
Operating Cash Flow Growth	0.00%	-671.69%	14.14%	10.05%	26.31%	11.31%
Free Cash Flow Firm Growth	0.00%	0.00%	-11.79%	25.99%	69.78%	-97.73%
Invested Capital Growth	0.00%	-13.19%	-79.85%	56.61%	-397.12%	-21.88%
Revenue Q/Q Growth	0.00%	0.00%	-1.13%	-84.79%	-15.34%	-5.34%
EBITDA Q/Q Growth	0.00%	0.00%	24.13%	18.90%	44.07%	-0.52%
EBIT Q/Q Growth	0.00%	0.00%	23.63%	19.11%	43.30%	-0.55%
NOPAT Q/Q Growth	0.00%	0.00%	23.46%	19.33%	43.17%	-0.55%
Net Income Q/Q Growth	0.00%	0.00%	23.85%	20.60%	5.25%	-6.89%
EPS Q/Q Growth	0.00%	0.00%	0.00%	18.34%	9.49%	44.64%
Operating Cash Flow Q/Q Growth	0.00%	-197.57%	37.77%	2.41%	1.35%	2.95%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	5.47%	48.97%	25.39%
Invested Capital Q/Q Growth	0.00%	0.00%	-121.25%	-471.17%	-67.86%	-158.70%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	0.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	0.00%	-242,812.37%	-26,012.17%	-1,300,939.43%	-715,585.78%	-984,552.36%
Operating Margin	0.00%	-243,836.90%	-26,456.76%	-1,307,147.47%	-737,882.34%	-998,192.36%
EBIT Margin	0.00%	-243,836.90%	-26,395.79%	-1,314,256.70%	-737,857.80%	-998,192.36%
Profit (Net Income) Margin	0.00%	-243,622.81%	-26,266.01%	-1,250,739.58%	-1,152,524.54%	-1,026,798.36%
Tax Burden Percent	100.00%	99.94%	99.61%	100.00%	170.44%	107.47%
Interest Burden Percent	90.91%	99.97%	99.90%	95.17%	91.65%	95.71%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-168.20%	-104.80%	-74.38%	-90.10%	-92.70%	-104.14%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	-100.55%	-71.91%	-90.03%	-54.17%	-87.36%
Return on Assets (ROA)	0.00%	-100.46%	-71.55%	-85.68%	-84.61%	-89.86%
Return on Common Equity (ROCE)	-168.20%	-104.80%	-74.38%	-90.10%	-110.98%	-124.66%
Return on Equity Simple (ROE_SIMPLE)	-168.20%	-53.92%	-96.67%	-137.79%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.76	-7.59	-8.56	-6.15	-2.25	-3.84
NOPAT Margin	0.00%	-170,685.83%	-18,519.73%	-915,003.23%	-516,517.64%	-698,734.65%
Net Nonoperating Expense Percent (NNEP)	-32.20%	-31.05%	-21.72%	-23.81%	-48.74%	-30.48%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-100.80%	-47.50%	-62.95%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	13,669.76%	2,146.28%	330,001.79%	268,844.50%	389,633.27%
R&D to Revenue	0.00%	0.00%	1,114.29%	201,103.42%	38,226.38%	0.00%
Operating Expenses to Revenue	0.00%	243,936.90%	26,556.76%	1,307,247.47%	737,982.34%	998,292.36%
Earnings before Interest and Taxes (EBIT)	-1.08	-11	-12	-8.83	-3.22	-5.49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1.05	-11	-12	-8.74	-3.12	-5.42
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	20.61	2.31	3.98	0.95	0.77	1.18
Price to Tangible Book Value (P/TBV)	20.61	2.31	3.98	0.95	0.77	1.18
Price to Revenue (P/Rev)	0.00	10,452.88	1,081.01	8,663.74	12,079.59	13,048.13
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	5,908.51	805.32	0.00	0.00	955.51
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.01	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.18	-1.01	-1.01	-1.02	-1.05	-1.09
Leverage Ratio	1.28	1.04	1.04	1.05	1.10	1.16
Compound Leverage Factor	1.16	1.04	1.04	1.00	1.00	1.11
Debt to Total Capital	1.03%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.69%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	-45.09%	0.00%
Common Equity to Total Capital	98.97%	100.00%	100.00%	100.00%	145.09%	100.00%
Debt to EBITDA	-0.01	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.65	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.01	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.90	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	9.04	35.72	47.63	-5.14	-9.80	-8.76
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	-19.72%	-19.71%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	4.47	35.48	27.20	15.68	6.80	4.29
Quick Ratio	4.32	34.83	26.91	15.23	5.90	4.03
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-7.57	-8.47	-6.27	-1.89	-3.74
Operating Cash Flow to CapEx	0.00%	-15,086.82%	-16,598.29%	-13,194.46%	0.00%	-95,353.61%
Free Cash Flow to Firm to Interest Expense	0.00	-59,634.04	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	-66,570.90	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	-67,012.15	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	139.62	2.37	2.24	3.79
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.69	0.01	0.01	0.02
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	2.61	153.98	163.25	96.23
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	2.61	153.98	163.25	96.23
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	-0.10	-0.12	-0.21	-0.09	-0.45	-0.55
Invested Capital Turnover	0.00	-0.04	-0.29	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	0.00	-0.01	-0.09	0.12	-0.36	-0.10
Enterprise Value (EV)	11	26	37	-0.37	-0.59	0.53
Market Capitalization	12	46	50	5.82	5.27	7.18
Book Value per Share	$0.04	$1.02	$0.61	$2.90	$2.32	$1.45
Tangible Book Value per Share	$0.04	$1.02	$0.61	$2.90	$2.32	$1.45
Total Capital	0.59	20	13	6.10	4.74	6.10
Total Debt	0.01	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-0.68	-20	-13	-6.19	-3.72	-6.65
Capital Expenditures (CapEx)	0.00	0.06	0.04	0.05	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.13	-0.20	-0.34	-0.22	-0.06	-0.69
Debt-free Net Working Capital (DFNWC)	0.56	20	12	5.97	3.66	3.05
Net Working Capital (NWC)	0.56	20	12	5.97	3.66	3.05
Net Nonoperating Expense (NNE)	0.22	3.24	3.58	2.26	2.77	1.80
Net Nonoperating Obligations (NNO)	-0.68	-20	-13	-6.19	-5.19	-6.65
Total Depreciation and Amortization (D&A)	0.02	0.05	0.18	0.09	0.10	0.08
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-4,561.03%	-732.04%	-32,841.67%	-14,171.10%	-124,643.64%
Debt-free Net Working Capital to Revenue	0.00%	449,876.20%	26,837.43%	888,310.57%	838,924.54%	553,708.91%
Net Working Capital to Revenue	0.00%	449,876.20%	26,837.43%	888,310.57%	838,924.54%	553,708.91%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($7.10)	($6.00)	($4.14)	($1.43)	($0.62)
Adjusted Weighted Average Basic Shares Outstanding	0.00	1.96M	2.01M	2.03M	2.96M	4.20M
Adjusted Diluted Earnings per Share	$0.00	($7.10)	$0.00	$0.00	($1.43)	($0.62)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	1.96M	2.02M	3.01M	2.96M	4.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	($7.10)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	1.53M	2.02M	3.01M	4.28M	4.32M
Normalized Net Operating Profit after Tax (NOPAT)	-0.76	-7.59	-7.79	-6.10	-2.25	-3.84
Normalized NOPAT Margin	0.00%	-170,685.83%	-16,853.15%	-908,018.65%	-516,517.64%	-698,734.65%
Pre Tax Income Margin	0.00%	-243,760.65%	-26,369.16%	-1,250,739.58%	-676,217.43%	-955,390.18%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-85,342.91	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	-59,740.04	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	-85,784.17	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	-60,181.29	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-4.73%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Myseum Inc - Warrants - Series A's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	20,938,439.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00
DEI Adjusted Shares Outstanding	2,093,844.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00	2,103,321.00
DEI Earnings Per Adjusted Shares Outstanding	-1.13	-0.64	-0.54	-0.47	-0.60	-0.40	-0.70	-0.58	-0.57	-0.44	-1.36
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-95.06%	-95.64%	-14.94%	-12.21%	-64.57%	-46.20%	-36.64%	-48.34%	429.03%	-33.70%	-12.05%
EBITDA Growth	3.12%	58.12%	32.53%	46.06%	51.83%	167.45%	13.61%	-11.87%	-3.41%	-212.54%	-100.43%
EBIT Growth	4.87%	58.30%	32.14%	45.54%	51.29%	164.62%	14.46%	-11.03%	-3.43%	-218.42%	-100.81%
NOPAT Growth	5.21%	58.51%	31.34%	45.54%	51.29%	191.07%	13.79%	-11.03%	-3.43%	-184.02%	-17.54%
Net Income Growth	11.00%	61.69%	34.90%	47.36%	49.95%	20.56%	-3.67%	-12.71%	-4.06%	-33.84%	-76.74%
EPS Growth	0.00%	61.93%	0.00%	0.00%	62.83%	56.72%	12.20%	12.12%	33.33%	206.90%	-86.11%
Operating Cash Flow Growth	2.66%	10.54%	16.05%	24.46%	51.66%	4.81%	19.41%	-12.34%	5.47%	42.36%	-5.09%
Free Cash Flow Firm Growth	72.85%	52.09%	23.54%	-52.72%	21.69%	212.66%	-57.22%	-133.89%	-240.21%	-153.56%	89.70%
Invested Capital Growth	-101.61%	56.61%	19.48%	4.22%	-1,591.58%	-397.12%	786.07%	514.52%	448.55%	-21.88%	-130.13%
Revenue Q/Q Growth	1.74%	-2.29%	-23.39%	15.27%	-58.94%	48.39%	-9.78%	-6.02%	320.51%	-81.40%	19.67%
EBITDA Q/Q Growth	-9.29%	41.72%	-12.62%	24.80%	2.40%	181.60%	-244.26%	15.96%	9.78%	11.19%	-156.90%
EBIT Q/Q Growth	-9.26%	41.29%	-12.31%	24.41%	2.28%	177.90%	-248.67%	15.27%	8.97%	10.81%	-152.10%
NOPAT Q/Q Growth	-9.26%	41.29%	-11.44%	23.83%	2.28%	209.79%	-205.49%	15.27%	8.97%	10.81%	-47.57%
Net Income Q/Q Growth	-3.38%	42.74%	-15.35%	22.90%	1.72%	9.11%	-50.53%	16.18%	9.26%	-16.90%	-98.78%
EPS Q/Q Growth	0.00%	40.71%	38.81%	19.51%	-27.27%	30.95%	-24.14%	19.44%	3.45%	210.71%	-316.13%
Operating Cash Flow Q/Q Growth	-39.34%	30.80%	-7.85%	27.35%	10.84%	-36.28%	8.70%	14.22%	24.98%	16.90%	-66.45%
Free Cash Flow Firm Q/Q Growth	-33.89%	-47.89%	-2.47%	24.74%	31.34%	312.76%	-243.00%	-3.23%	0.13%	66.50%	72.50%
Invested Capital Q/Q Growth	93.01%	-471.17%	-22.61%	-95.53%	-23.53%	-67.86%	269.22%	18.13%	3.87%	-158.70%	58.17%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-1,439,400.57%	-858,521.05%	-1,262,116.03%	-823,385.43%	-1,957,206.45%	1,076,302.17%	-1,720,987.95%	-1,783,130.77%	-382,585.37%	-1,826,903.28%	-3,921,883.56%
Operating Margin	-1,452,657.71%	-872,867.84%	-1,269,785.50%	-839,141.06%	-1,997,070.97%	1,034,281.52%	-1,727,663.86%	-1,803,625.64%	-390,427.13%	-1,872,431.15%	-2,308,863.01%
EBIT Margin	-1,452,678.29%	-872,867.84%	-1,279,600.76%	-839,141.06%	-1,997,070.97%	1,048,373.91%	-1,727,663.86%	-1,803,625.64%	-390,427.13%	-1,872,431.15%	-3,944,479.45%
Profit (Net Income) Margin	-1,351,188.57%	-791,781.29%	-1,192,219.08%	-797,422.52%	-1,908,803.23%	-1,169,167.39%	-1,950,734.94%	-1,739,985.90%	-375,451.52%	-2,360,018.03%	-3,920,013.70%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	-107.45%	116.26%	100.00%	100.00%	137.52%	100.00%
Interest Burden Percent	93.01%	90.71%	93.17%	95.03%	95.58%	103.79%	97.12%	96.47%	96.16%	91.65%	99.38%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-9,342.51%	0.00%	0.00%	0.00%	0.00%	0.00%	-1,448.58%	-1,170.07%	-478.53%	0.00%	-3,294.20%
ROIC Less NNEP Spread (ROIC-NNEP)	-9,337.14%	0.00%	0.00%	0.00%	0.00%	0.00%	-1,439.21%	-1,163.28%	-471.34%	0.00%	-3,264.02%
Return on Net Nonoperating Assets (RNNOA)	8,941.88%	0.00%	0.00%	0.00%	0.00%	0.00%	1,371.57%	1,095.36%	440.00%	0.00%	3,115.88%
Return on Equity (ROE)	-400.64%	-90.10%	-90.74%	-91.24%	-90.13%	-92.70%	-77.01%	-74.71%	-38.54%	-104.14%	-178.32%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-390.34%	-547.41%	-539.38%	0.00%	0.00%
Operating Return on Assets (OROA)	-540.18%	-59.79%	-93.76%	-69.49%	-160.80%	76.96%	-89.78%	-88.17%	-39.18%	-163.87%	-316.65%
Return on Assets (ROA)	-502.44%	-54.24%	-87.36%	-66.04%	-153.70%	-85.83%	-101.37%	-85.06%	-37.67%	-206.54%	-314.68%
Return on Common Equity (ROCE)	-400.63%	-90.10%	-95.45%	-98.22%	-111.54%	-110.98%	-95.66%	-98.40%	-59.54%	-124.66%	-216.08%
Return on Equity Simple (ROE_SIMPLE)	-141.46%	0.00%	-110.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.78	-1.04	-1.16	-0.89	-0.87	0.95	-1.00	-0.98	-0.90	-0.80	-1.18
NOPAT Margin	-1,016,860.40%	-611,007.49%	-888,849.85%	-587,398.74%	-1,397,949.68%	1,034,281.52%	-1,209,364.70%	-1,262,537.95%	-273,298.99%	-1,310,701.80%	-1,616,204.11%
Net Nonoperating Expense Percent (NNEP)	-5.38%	-3.26%	-4.70%	-4.33%	-5.26%	-35.63%	-9.37%	-6.79%	-7.19%	-10.81%	-30.18%
Return On Investment Capital (ROIC_SIMPLE)	-	-17.13%	-19.49%	-17.62%	-20.23%	20.07%	-12.85%	-14.90%	-15.63%	-13.10%	-30.52%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	397,713.71%	295,763.16%	379,580.92%	321,666.89%	611,641.94%	-206,547.83%	583,186.75%	834,048.72%	137,462.50%	643,542.62%	900,360.27%
R&D to Revenue	217,152.57%	205,360.82%	178,563.36%	149,707.28%	586,245.16%	-713,892.39%	0.00%	6,410.26%	0.00%	-18,032.79%	0.00%
Operating Expenses to Revenue	1,452,757.71%	872,967.84%	1,269,885.50%	839,241.06%	1,997,170.97%	-1,034,181.52%	1,727,763.86%	1,803,725.64%	390,527.13%	1,872,531.15%	2,308,963.01%
Earnings before Interest and Taxes (EBIT)	-2.54	-1.49	-1.68	-1.27	-1.24	0.96	-1.43	-1.41	-1.28	-1.14	-2.88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2.52	-1.47	-1.65	-1.24	-1.21	0.99	-1.43	-1.39	-1.25	-1.11	-2.86
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.74	0.95	0.59	0.55	0.55	0.77	1.54	1.16	1.14	1.18	1.74
Price to Tangible Book Value (P/TBV)	0.74	0.95	0.59	0.55	0.55	0.77	1.72	1.34	1.34	1.18	1.74
Price to Revenue (P/Rev)	1,252.45	8,663.74	6,226.36	5,366.96	7,596.36	12,079.59	40,682.50	33,941.89	16,422.47	13,048.13	12,448.54
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	8.26	2.65	2.29	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	16,138.66	7,529.39	3,674.50	955.51	4,866.06
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.96	-1.02	-1.01	-1.03	-1.02	-1.05	-0.95	-0.94	-0.93	-1.09	-0.95
Leverage Ratio	1.05	1.05	1.06	1.07	1.09	1.10	1.08	1.11	1.16	1.16	1.15
Compound Leverage Factor	0.97	0.95	0.99	1.01	1.04	1.14	1.05	1.07	1.12	1.06	1.15
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.70%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.70%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	-14.50%	-21.60%	-65.25%	-45.09%	-31.66%	-39.42%	-46.09%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	114.49%	121.60%	165.24%	145.09%	131.66%	139.41%	145.39%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.25	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-1.42	-1.42	-5.10	-7.63	-10.35	-7.23	5.04	-2.50	-6.17	-6.77	-14.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	-5.19%	-7.65%	-23.76%	-19.72%	-24.22%	-31.71%	-54.50%	-19.71%	-21.18%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	16.56	15.68	14.07	13.20	8.96	6.80	10.30	8.98	5.72	4.29	3.09
Quick Ratio	15.96	15.23	13.56	12.94	8.57	5.90	10.08	8.87	5.41	4.03	2.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-0.79	-1.16	-1.19	-0.90	-0.62	1.31	-1.87	-2.10	-2.09	-0.70	-0.19
Operating Cash Flow to CapEx	-11,441.57%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	26.46	2.37	2.09	4.20	3.05	2.24	1.74	1.53	2.77	3.79	3.38
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.05	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.03
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	13.79	153.98	174.91	86.89	119.78	163.25	210.25	238.70	131.93	96.23	108.15
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	13.79	153.98	174.91	86.89	119.78	163.25	210.25	238.70	131.93	96.23	108.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-0.02	-0.09	-0.11	-0.22	-0.27	-0.45	0.76	0.90	0.93	-0.55	-0.23
Invested Capital Turnover	0.01	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	-0.99	0.12	0.03	0.01	-0.25	-0.36	0.87	1.11	1.20	-0.10	-0.99
Enterprise Value (EV)	-1.96	-0.37	-2.91	-2.97	-3.44	-0.59	6.26	2.37	2.13	0.53	2.63
Market Capitalization	5.53	5.82	4.04	3.37	3.91	5.27	16	11	9.54	7.18	6.72
Book Value per Share	$0.36	$2.90	$2.44	$2.03	$2.35	$2.32	$2.51	$2.19	$1.97	$1.45	$0.90
Tangible Book Value per Share	$0.36	$2.90	$2.44	$2.03	$2.35	$2.32	$2.24	$1.90	$1.68	$1.45	$0.90
Total Capital	7.48	6.10	5.98	5.03	4.29	4.74	7.81	6.61	5.73	6.10	3.87
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-7.50	-6.19	-6.09	-5.25	-4.55	-3.72	-7.05	-5.71	-4.76	-6.65	-4.09
Capital Expenditures (CapEx)	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.19	-0.22	-0.22	-0.30	-0.33	-0.06	-0.54	-0.57	-0.57	-0.69	-0.43
Debt-free Net Working Capital (DFNWC)	7.31	5.97	5.87	4.95	4.23	3.66	6.51	5.14	4.23	3.05	1.94
Net Working Capital (NWC)	7.31	5.97	5.87	4.95	4.23	3.66	6.51	5.14	4.19	3.05	1.94
Net Nonoperating Expense (NNE)	0.59	0.31	0.40	0.32	0.32	2.03	0.62	0.37	0.34	0.64	1.68
Net Nonoperating Obligations (NNO)	-7.50	-6.19	-6.09	-5.25	-4.55	-5.19	-7.05	-5.71	-4.76	-6.65	-4.09
Total Depreciation and Amortization (D&A)	0.02	0.02	0.02	0.02	0.02	0.03	0.01	0.02	0.03	0.03	0.02
Debt-free, Cash-free Net Working Capital to Revenue	-4,337.61%	-32,841.67%	-33,617.72%	-47,768.15%	-63,326.02%	-14,171.10%	-140,367.53%	-181,489.52%	-98,213.43%	-124,643.64%	-80,187.96%
Debt-free Net Working Capital to Revenue	165,357.91%	888,310.57%	904,157.01%	788,061.78%	820,595.15%	838,924.54%	1,676,822.42%	1,632,665.71%	728,625.82%	553,708.91%	358,429.81%
Net Working Capital to Revenue	165,357.91%	888,310.57%	904,157.01%	788,061.78%	820,595.15%	838,924.54%	1,676,822.42%	1,632,665.71%	721,741.14%	553,708.91%	358,429.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.13)	($0.67)	($0.56)	($0.33)	($0.42)	($0.29)	($0.36)	($0.29)	($0.28)	$0.31	($0.67)
Adjusted Weighted Average Basic Shares Outstanding	2.09M	2.03M	2.81M	3.01M	3.01M	2.96M	4.09M	4.21M	4.22M	4.20M	4.28M
Adjusted Diluted Earnings per Share	$0.00	($0.67)	$0.00	$0.00	($0.42)	($0.29)	($0.36)	($0.29)	($0.28)	$0.31	($0.67)
Adjusted Weighted Average Diluted Shares Outstanding	2.10M	2.03M	3.01M	3.01M	3.01M	2.96M	4.09M	4.21M	4.22M	4.20M	4.28M
Adjusted Basic & Diluted Earnings per Share	$0.00	($0.67)	$0.00	$0.00	$0.00	($0.29)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.10M	3.01M	3.01M	3.01M	3.01M	4.28M	4.21M	4.21M	4.26M	4.32M	5.07M
Normalized Net Operating Profit after Tax (NOPAT)	-1.78	-1.04	-1.16	-0.89	-0.87	0.67	-1.00	-0.98	-0.90	-0.80	-1.18
Normalized NOPAT Margin	-1,016,860.40%	-611,007.49%	-888,849.85%	-587,398.74%	-1,397,949.68%	723,997.07%	-1,209,364.70%	-1,262,537.95%	-273,298.99%	-1,310,701.80%	-1,616,204.11%
Pre Tax Income Margin	-1,351,188.57%	-791,781.29%	-1,192,219.08%	-797,422.52%	-1,908,803.23%	1,088,114.13%	-1,677,861.45%	-1,739,985.90%	-375,451.52%	-1,716,173.77%	-3,920,013.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-3.76%	-4.73%	-1.15%	0.00%	0.00%	0.00%	0.00%	-3.37%	-3.91%	0.00%	0.00%

Financials Breakdown Chart

Myseum Inc - Warrants - Series A Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Myseum Inc - Warrants - Series A's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 5 years, Myseum Inc - Warrants - Series A's net income changed from -$979.47 thousand in 2020 to -$5.65 million in 2025, a change of 476.6%.

Myseum Inc - Warrants - Series A's total operating income in 2025 was -$5.49 million, based on the following breakdown:

Total Gross Profit: $550.00
Total Operating Expenses: $5.49 million

Over the last 5 years, Myseum Inc - Warrants - Series A's total revenue changed from $0.00 in 2020 to $550.00 in 2025, a change of 55,000.0%.

Myseum Inc - Warrants - Series A's total liabilities were at $1.09 million at the end of 2025, a 73.4% increase from 2024, and a 574.6% increase since 2020.

In the past 5 years, Myseum Inc - Warrants - Series A's cash and equivalents has ranged from $690.42 thousand in 2020 to $20.20 million in 2021, and is currently $749.03 thousand as of their latest financial filing in 2025.

Over the last 5 years, Myseum Inc - Warrants - Series A's book value per share changed from 0.04 in 2020 to 1.45 in 2025, a change of 3,205.9%.

Related Companies

Financial statements for NASDAQ:MYSEW last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Myseum Inc - Warrants - Series A (MYSEW) Financials

Financials Breakdown Chart

Myseum Inc - Warrants - Series A Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Myseum Inc - Warrants - Series A (MYSEW) Financials

Annual Income Statements for Myseum Inc - Warrants - Series A

Quarterly Income Statements for Myseum Inc - Warrants - Series A

Annual Cash Flow Statements for Myseum Inc - Warrants - Series A

Quarterly Cash Flow Statements for Myseum Inc - Warrants - Series A

Annual Balance Sheets for Myseum Inc - Warrants - Series A

Quarterly Balance Sheets for Myseum Inc - Warrants - Series A

Annual Metrics And Ratios for Myseum Inc - Warrants - Series A

Quarterly Metrics And Ratios for Myseum Inc - Warrants - Series A

Financials Breakdown Chart

Myseum Inc - Warrants - Series A Financials - Frequently Asked Questions

When does Myseum Inc - Warrants - Series A's fiscal year end?

How has Myseum Inc - Warrants - Series A's net income changed over the last 5 years?

What is Myseum Inc - Warrants - Series A's operating income?

How has Myseum Inc - Warrants - Series A's revenue changed over the last 5 years?

How much debt does Myseum Inc - Warrants - Series A have?

How much cash does Myseum Inc - Warrants - Series A have?

How has Myseum Inc - Warrants - Series A's book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools